XML 38 R26.htm IDEA: XBRL DOCUMENT v3.3.1.900
Equity (Tables)
3 Months Ended
Dec. 31, 2015
Equity [Abstract]  
Schedule of Stock Options Activity
The following table summarizes stock option activity under the Equity Plans for the three months ended December 31, 2015:


Number of Shares
 
Weighted Average Exercise Price
 
Weighted Average
Remaining Contractual Life
(in years)
 
Aggregate Intrinsic Value (*) (in thousands)
Outstanding as of September 30, 2015
696,459

 
$22.47
 
 
 
 
Granted
9,200

 
$7.29
 
 
 
 
Exercised
(37,413
)
 
$4.98
 
 
 
$
80

Forfeited
(2,200
)
 
$5.61
 
 
 
 
Expired
(13,709
)
 
$29.56
 
 
 
 
Outstanding as of December 31, 2015
652,337

 
$23.17
 
2.80
 
$
256

Exercisable as of December 31, 2015
601,638

 
$24.59
 
2.26
 
$
240

Vested and expected to vest as of December 31, 2015
642,096

 
$23.43
 
2.70
 
$
254


(*) Intrinsic value for stock options represents the “in-the-money” portion or the positive variance between a stock option's exercise price and the underlying stock price. For the three months ended December 31, 2014, the intrinsic value of options exercised was $49,000.

Schedule of Valuation Assumptions
The fair value of each stock option grant was estimated on the date of grant using the Black-Scholes option valuation model, adhering to the straight-line attribution approach using the following weighted-average assumptions, of which the expected term and stock price volatility rate are highly subjective:

 
For the three months ended December 31,
 
2015
 
2014
Black-Scholes weighted average assumptions:
 
 
 
Expected dividend rate
%
 
%
Expected stock price volatility rate
61.6
%
 
82.5
%
Risk-free interest rate 
1.8
%
 
1.9
%
Expected term (in years)
6.0

 
6.0

 
 
 
 
Weighted average grant date fair value per share of stock options granted:
$4.18
 
$
3.63

Schedule of Restricted Stock Activity
The following table summarizes the activity related to RSUs for the three months ended December 31, 2015:

Restricted Stock Activity
 
Restricted Stock Units
 
 
Number of Shares
 
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2015
 
570,231

 
$5.26
Granted
 
12,000

 
$7.82
Vested
 
(266
)
 
$4.35
Forfeited
 
(7,166
)
 
$5.15
Non-vested as of December 31, 2015
 
574,799

 
$5.31
Schedule of Stock-based Compensation Expense - By Award Type
The effect of recording stock-based compensation expense was as follows:

Stock-based Compensation Expense - by award type
For the three months ended December 31,
(in thousands)
2015
 
2014
Employee stock options
$
6

 
$
177

Restricted stock awards and units
266

 
1,259

Employee stock purchase plan
55

 
50

401(k) match in common stock

 
80

Outside director fees in common stock
36

 
208

Total stock-based compensation expense
$
363

 
$
1,774

Schedule Stock-based Compensation Expense - By Expense Type
Stock-based Compensation Expense - by expense type
For the three months ended December 31,
(in thousands)
2015
 
2014
Cost of revenue
$
69

 
$
104

Selling, general, and administrative
188

 
1,565

Research and development
106

 
105

Total stock-based compensation expense
$
363

 
$
1,774

Schedule of Earnings Per Share, Basic and Diluted
Income (Loss) Per Share
The following table sets forth the computation of basic and diluted net income (loss) per share:

Basic and Diluted Net (Loss) Income Per Share
 
For the three months ended December 31,
(in thousands, except per share)
 
2015
 
2014
 
 
 
Numerator:
 
 
 
 
   Loss from continuing operations
 
$
(134
)
 
$
(3,130
)
   Income from discontinued operations
 
1,121

 
59,258

Undistributed earnings allocated to common shareholders for basic and diluted net (loss) income per share
 
987

 
56,128

Denominator:
 
 
 
 
Denominator for basic net (loss) income per share - weighted average shares outstanding
 
25,697

 
31,217

Dilutive options outstanding, unvested stock units and ESPP
 

 

Denominator for diluted net (loss) income per share - adjusted weighted average shares outstanding
 
25,697

 
31,217

 
 
 
 
 
Net (loss) income per basic share:
 
 
 
 
   Continuing operations
 
$
0.00

 
$
(0.10
)
   Discontinued operations
 
0.04

 
1.90

Net income per basic share
 
$
0.04

 
$
1.80

 
 
 
 
 
Net (loss) income per diluted share:
 
 
 
 
   Continuing operations
 
$
0.00

 
$
(0.10
)
   Discontinued operations
 
$
0.04

 
$
1.90

Net income per diluted share
 
$
0.04

 
$
1.80

Weighted average antidilutive options, unvested restricted stock units and awards, warrants and ESPP shares excluded from the computation
 
858

 
2,649

 
 
 
 
 
Average market price of common stock
 
$
6.93

 
$
5.29

Schedule of Common Stock Reserved for Future Issuances
As of December 31, 2015, we had common stock reserved for the following future issuances:
Future Issuances
Number of Common Stock Shares Available for Future Issuances
Exercise of outstanding stock options
652,337

Unvested restricted stock units
574,799

Purchases under the employee stock purchase plan
971,728

Issuance of stock-based awards under the Equity Plans
609,787

Purchases under the officer and director share purchase plan
88,741

Issuance of deferred stock-based awards under the Directors' Stock Award Plan, as amended
15,152

Grants of stock-based awards under the 2007 Directors' Stock Award Plan, as amended
193,010

Total reserved
3,105,554